Memantine: Marketed in EU to treat Alzheimer's disease (AD)

Preliminary data from a double-blind trial showed that Memantine plus acetylcholinesterase inhibitors failed to significantly improve

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.